IMPROCAS - Improved Prediction of Ovarian Cancer Surgery

Aarhus University0 个研究点目标入组 40 人开始时间: 2023年7月13日最近更新: 2024年7月22日

适应症

试验速览

暂无简介。

•Suspected epithelial ovarian cancer (and referred to dept. of Gynaecology and Obstetrics, AUH, and selected for an MDT), -Understanding Danish, -Age 18 – 85 years

•Contraindications for MRI with contrast: -eGFR less than 30 ml/min/1.73m2 -Significant cardiac disease such as severe left ventricular outflow obstruction -Significant obstructive lung disease or severe asthma -Pacemaker, implantable cardiac defibrillator, neurostimulator or cochlear implant -Metal foreign bodies such as fragments and irremovable piercings -Unsafe medical implants (safety of heart valves, hips and the like must be confirmed) -Claustrophobia -Largest circumference including arms > 160 cm, Substantial cognitive disability that would influence the patients’ ability to either give truly informed consent or listen to / comply with safety-related instructions., Uncontrolled diabetes or the patient presenting with a diabetic emergency such as hypoglycaemia or diabetic ketoacidosis, Severe renovascular disease, Any other malign disease or recidiv of a former malign disease present within the last 3-5 years (except benign basal basocelluar carcinoma (BBC)), Pregnancy, Allergy to pyruvate

发起方